Skip to content

New Standards in Elemental Analysis: Analytik Jena Introduces PlasmaQuant 9200 Series

Jena, June 26, 2025 – Analytik Jena, a leading provider of analytical measurement technology, has opened a new chapter in chemical elemental analysis with the PlasmaQuant 9200 Series. The innovative ICP-OES Series (Inductively Coupled Plasma Optical Emission Spectrometry) combines the highest precision with a compact design and sets new standards in laboratory analytics. The PlasmaQuant 9200 Series impresses with its market-leading spectral resolution and unsurpassed matrix tolerance, enabling precise analyses even with complex samples such as organic matrices. Two model variants are available: The standard version, PlasmaQuant 9200, with a resolution of 6 pm @ 200 nm, is ideal for routine use in contract and quality control laboratories. The Elite version achieves a resolution of 2 pm @ 200 nm and is specially designed for demanding applications in the electroplating, metal, and specialty chemicals industries. Both models cover a wide spectral range from 160 to 900 nm and offer low detection limits… 

FAQ: What happened with the acquisition of LADR by Sonic Healthcare?

  • News

The acquisition of the LADR laboratory group Dr. Kramer & Kollegen by Sonic Healthcare has attracted a lot of attention in the laboratory medicine industry. Here we answer the most frequently asked questions about the acquisition, its status, and its impact. 1. What is the LADR laboratory group? The LADR laboratory group Dr. Kramer & Kollegen is one of the leading providers of laboratory diagnostic services in Germany. Founded in 1945 and headquartered in Geesthacht near Hamburg, LADR employs over 2,800 people and operates a network of individual and hospital laboratories. In addition to Germany, LADR is also active in Poland and Finland (through a joint venture interest). The group generates annual sales of approximately 370 million euros and an EBITDA of around 50 million euros. 2. Who is Sonic Healthcare? Sonic Healthcare Limited is an Australian company headquartered in Sydney, operating globally in laboratory medicine, pathology, radiology, and primary care. It is the… 

Germany's Useless Commissions in Healthcare

  • News

Commissions are an established instrument in Germany for tackling complex social and political challenges, including in the healthcare sector. They are intended to pool expert knowledge, develop evidence-based solutions, and prepare political decisions. However, the efficiency of such bodies is increasingly being criticized: they are said to be costly, slow, and often superfluous. These weaknesses are particularly serious in the medical context, where rapid and precise measures can save lives. This report analyzes the problem of useless commissions in the German healthcare system, highlights specific examples, relies on facts and figures, and questions why many of these bodies consume more resources than they provide benefit. Finally, reform proposals are outlined to increase efficiency. The Role of Commissions in the Healthcare System In the German healthcare system, commissions are used to analyze topics such as hospital reforms, digitalization, pandemic control, or care structures. They consist of medical professionals, health economists, representatives of health insurance funds, patient organizations, and politicians. The goal is to... 

Guide: Surviving the 2025 Heatwave in Germany – A Medical Perspective

  • News

The summer of 2025 in Germany is expected to be marked by intense heatwaves, which are becoming more frequent, longer, and more extreme due to climate change. According to forecasts from the European Centre for Medium-Range Weather Forecasts and the Max Planck Institute for Meteorology, temperatures of up to 38°C could be reached in Germany and up to 40°C in neighboring regions such as France, particularly in the west and southwest. These conditions pose significant health risks, especially for vulnerable groups such as the elderly, children, pregnant women, and individuals with pre-existing conditions. Based on peer-reviewed studies, statistics, and current recommendations from the Robert Koch Institute (RKI), the Federal Environment Agency (UBA), and the Federal Ministry of Health (BMG), this guide offers comprehensive medical strategies for safely surviving the heatwave. 1. Health Risks of Heatwaves Heatwaves are periods of sustained high temperatures, often combined with high humidity levels, that overwhelm the body's thermoregulatory capabilities. According to the RKI, in the summers of 2023...

Biomarkers and Blood Values as Warning Signs for Sudden Cardiac Death

  • News

Sudden cardiac death (SCD) is an acute, often unforeseen complication, usually triggered by cardiac arrhythmias such as ventricular fibrillation. Certain biomarkers and blood values can serve as an early warning system to identify the risk. This article precisely and evidence-based illuminates the most important parameters. 1. Definition and Relevance Biomarkers are measurable indicators in the blood that point to pathophysiological processes. In the context of SCD, they signal cardiac damage, inflammation, or electrical instability. Early detection is crucial, as SCD often occurs without warning, especially in individuals with coronary heart disease (CHD), cardiomyopathies, or genetic predispositions. 2. Important Biomarkers and Blood Values The following parameters are particularly relevant: 3. Clinical Significance Elevated levels of these markers alone are not specific to SCD, but in combination with clinical risk factors (e.g., atrial fibrillation, family history of SCD), they increase predictive accuracy. Regular blood analyses, especially in at-risk patients, can help identify individuals at risk. Additional diagnostic tools such as ECG, ... 

Massive violations in working time recording at university hospitals

Marburger Bund speaks of "systematic manipulation" Berlin, June 26, 2025 – A nationwide survey by the Marburger Bund reveals serious deficiencies in working time recording at German university hospitals. According to the doctors' union, the majority of hospitals violate the collective agreement TV-Ärzte, which mandates tamper-proof, electronic time tracking. The results, based on a survey of around 3,500 doctors, paint an alarming picture of unrecorded overtime, lack of occupational safety, and systematic disregard for contractual obligations. Survey results: Only 17 percent with collective agreement-compliant time tracking The survey, conducted between March 31 and April 23, 2025, questioned doctors at the approximately 20,000 employees covered by collective agreements at university hospitals. Hospitals in Hamburg, Berlin, Mainz, and Hesse are not covered by the TV-Ärzte as different regulations apply there. When asked "How is your working time currently recorded?", only 17 percent stated that their working time... 

6G: Revolutionary impulses for biotech

Berlin, June 26, 2025 – The 6G mobile communication standard, planned for introduction in 2030, promises to transform numerous industries with data rates of up to 1 Tbit/s, latency times under 100 microseconds, and seamless global connectivity. The biotechnology sector, in particular, faces a paradigm shift as 6G enables innovative applications and efficiency gains. Impact on the Biotechnology Sector Economic Potential According to a study by VDI/VDE, 6G could increase Germany's GDP by 1.8% by 2050, with strong effects in the healthcare sector. The biotechnology sector benefits from new markets, such as for telemedicine services or AI-supported diagnostics, while the shortage of skilled workers is mitigated by automation. However, the transition requires investments in infrastructure and qualifications, which could increase costs for companies like BioNTech or Moderna in the short term. Conclusion 6G will sustainably change the biotechnology sector through faster, connected, and smarter systems. From remote surgery to digital twins, the standard opens up new possibilities… 

IAB Labor Market Barometer Rises Slightly, Unemployment Remains a Problem

  • News

Nuremberg, June 26, 2025 – The IAB Labor Market Barometer recorded its third consecutive increase in June 2025, but remained below the neutral mark of 100 points with 99.1 points, as announced by the Institute for Employment Research (IAB). The leading indicator, which forecasts the development of the German labor market for the next three months, improved by 0.2 points. "The labor market barometer is laboriously climbing out of the valley it slipped into until March," explained Enzo Weber, head of the "Forecasts and Macroeconomic Analyses" research area at the IAB. The European Labour Market Barometer, on the other hand, stagnated at 99.6 points, reflecting a continued slump in European labor markets. The component for predicting unemployment in Germany remained clearly in the negative range despite an increase of 0.3 points to 97.8 points, the researchers emphasized. "The labor market is consolidating somewhat. Nevertheless, unemployment will likely… 

NCOA Funds 18 Organizations for Innovative Fall Prevention in Older Adults

Arlington, Va., June 25, 2025 – The National Council on Aging (NCOA) has selected 18 organizations to test new approaches to fall prevention for older adults. Through the Administration for Community Living (ACL) supported ACL Innovation Lab, organizations will receive up to $290,000 over two years to implement and test the effectiveness of activities from a new fall prevention taxonomy. “Evidence-based fall prevention programs have been successful, but we need to explore new ways that are adapted to the diverse resources and needs of communities,” said Emily Nabors, Associate Director of Innovation at the NCOA Center for Healthy Aging. Funded organizations can choose activities that complement their existing services and are sustainable. Activities include three categories: physical activity (e.g., balance exercises), home modifications and assistive devices (e.g., proper use of walkers), and education and behavior change (e.g., managing fear of falling).… 

Sysmex America receives FDA clearance for CN-6000™ hemostasis analyzer

Chicago, June 25, 2025 – Sysmex America, Inc., a leading provider of diagnostic solutions for hematology, hemostasis, urinalysis, flow cytometry, and informatics, has received U.S. Food and Drug Administration (FDA) clearance for the CN-6000™ automated hemostasis analyzer. The clearance includes reagents for five common hemostasis tests: Prothrombin Time (PT) and PT INR with Dade® Innovin®, Activated Partial Thromboplastin Time (APTT) with Dade® Actin® FSL, Fibrinogen (Fbg) with Dade® Thrombin Reagent, Antithrombin (AT) with INNOVANCE® Antithrombin, and D-Dimer with INNOVANCE® D-Dimer. “Our hemostasis solutions combine advanced technology, reliable reagents, and award-winning service to provide laboratories with accurate results for diagnosing bleeding or clotting disorders,” said Dan Zortman, CEO of Sysmex America. The CN-6000™ offers high throughput and fully automated testing in a space-saving design that can be adapted to the needs of various laboratories. An optional sample loader with expandable capacity is available for high-volume laboratories.…